Tiefenbacher Group International Social Day
TIEFENBACHER SOCIAL DAY GOES GLOBAL Last week marked a very special moment for all of us at Tiefenbacher Group. It was our very first international SocialDay. Across all our locations, from Hamburg…
Tiefenbacher Group Celebrating International Yoga Day
Tiefenbacher Group is celebrating International Yoga Day with Young Minds in India We are delighted to share that our colleagues from Tiefenbacher Laboratories celebrated International Yoga Day this…
Tiefenbacher Group Football Cup 2025
The Tiefenbacher Group Football Cup 2025 winner is “The Lawn Mowers” This year, more than 200 people (employees and their families) turned up to join the Tiefenbacher Group Football Cup. They spent a…
Tiefenbacher Group celebrates Pharmacy Day
Last Saturday, Germany and Tiefenbacher Group celebrated Pharmacy Day - Tag der Apotheke! We at Tiefenbacher Group want to take this moment to thank all pharmacists for their…
Tiefenbacher Group World Environment Day
World Environment Day 2025 – Our Commitment to a Healthier Planet June 5 marks World Environment Day, established by the United Nations in 1972 to raise global awareness and inspire…
Tiefenbacher Laboratories Supporting Women’s Health
Today Tiefenbacher Laboratories celebrates International Day of Action for Women's Health.The theme of this global day, “Our Health. Our Rights. Our Lives.”, resonates strongly with our mission to…
Tiefenbacher Group celebrates World Hypertension Day
“Measure Your Blood Pressure Accurately, Control It, Live Longer!”Last Saturday was World Hypertension Day, and at Tiefenbacher Group, we’re joining the global movement to raise awareness about high…
Tiefenbacher Group Family Day
Family, Community & Elbe ViewsLast Friday, as Hamburg kicked off the celebrations for the 836th Harbour birthday with its iconic parade of tall ships and maritime flair, we at Tiefenbacher Group…
New Canteen at Tiefenbacher Laboratories
Grand Opening of Our New Canteen at Tiefenbacher Laboratories!We are thrilled to announce the opening of our brand-new canteen in the newly built facility of Tiefenbacher Laboratories in Hyderabad,…
Tiefenbacher Group’s New Packaging Line in Cyprus
Tiefenbacher Group is expanding the production capacity with a new packaging line in Cyprus to make medicines more affordable and available.At Tiefenbacher Group, we believe that…
Tiefenbacher Group school visiting in India
Education. Opportunity. Impact.Tiefenbacher Group is proud to share another exciting milestone from the primary school in Gaddapotharam Village, India — the number of students has grown to nearly 80…
Tiefenbacher Group celebrates World Health Day
Today is World Health DayThe date of 7 April marks the anniversary of the founding of the World Health Organization (WHO) in 1948 – and a global reminder that health is a human right. At Tiefenbacher…
Tiefenbacher Group celebrating new buildings in Hyderabad
Exciting News from Tiefenbacher Group!We are thrilled to announce the grand inauguration of our newly constructed development and production facilities in Hyderabad, India! This marks…
Exciting Days at DCAT in New York!
Our team sends greetings and impressions from the Big Apple!As we approach the final stretch of DCAT Week 2025 in New York, we reflect on an incredibly successful event so far! The Tiefenbacher Group…
Tiefenbacher Group, OnDosis and Star celebrate iF Design Award for OYSTA
We are proud to announce that OYSTA has been honored with the prestigious iF Design Award for its excellence in digital innovation and user-centric design. This award is a testament to our shared…
Lindus Health and Tiefenbacher Group Launching Clinical Trial
Lindus Health and Tiefenbacher Group are launching a clinical trial to advance ME/CFS research and treatment. At Tiefenbacher Group, we are committed to driving innovation in healthcare and…
Tiefenbacher Pharmaceuticals Launch: Varenicline in UK
Tiefenbacher Pharmaceuticals successfully prepares the launch of Varenicline in the United Kingdom We at Tiefenbacher Pharmaceuticals strongly believe that our high-quality medicines should be…
Tiefenbacher Group celebrating World Cancer Day
The 4th of February is the day to raise awareness of cancer worldwide. Tiefenbacher Group joins the initiative led by the Union for International Cancer Control (UICC) to remind people that cancer…
Tiefenbacher Pharmaceuticals New Market Launch: Amifampridine
Tiefenbacher Pharmaceuticals Successfully Prepares the Launch of Amifampridine Across Europe At Tiefenbacher Pharmaceuticals, we are deeply committed to making high-quality, life-changing…
Tiefenbacher Group provides insights into practice
Insights into Practice: Tiefenbacher Group at the University of Kiel and Dusseldorf Last week, Tiefenbacher Group had the fantastic opportunity to get in touch with pharmacy students at the…
Tiefenbacher Group celebrating International Day of Education
Every day is a new opportunity to learn something amazing! On this International Day of Education, Tiefenbacher Group joins the global community in celebrating the transformative power of learning in…
Tiefenbacher Group finalizing renovation
We are thrilled to announce the completion of the Tiefenbacher Group renovation of our office at the Port of Hamburg.The finalization of the 4th floor marks a significant milestone, ensuring that our…
Tiefenbacher Group wishes you a happy new year!
As 2024 draws to a close, the Tiefenbacher Group wishes you a Happy New Year and likes to share some of the year's highlights with you.This year we celebrated many achievements:…
Tiefenbacher Laboratories Celebrating End-of-Year Fest
Last week, Tiefenbacher Laboratories hosted its much-anticipated End-of-Year Party at our R&D and manufacturing site in India. This annual fest brought together our dedicated employees from…
Tiefenbacher Group employees together for a good cause
We are delighted to inform you that a significant part of our Tiefenbacher Group employees has once again raised a substantial amount for a good cause this year. On behalf of the beneficiary…
Tiefenbacher Group Christmas Party 2024
Last week, our team came together to celebrate the Tiefenbacher Group Christmas Party in style at the stunning Restaurant am Kai in Hamburg. It was an evening filled with delicious food, delightful…
Tiefenbacher Laboratories Football Event
1st Tiefenbacher Laboratories Soccer event This month marked an exciting milestone as we hosted the 1st Tiefenbacher Football Cup in India! Stepping away from our traditional cricket tournaments, we…
Tiefenbacher Group and Pharmacists Without Borders
We are proud to share an update on our partnership with Pharmacists Without Borders ("Apotheker ohne Grenzen Deutschland e.V."). At Tiefenbacher Group, we believe our culture of caring is essential…
Celebrating World Children’s Day at Tiefenbacher Group
Every year on November 20th, the world comes together to celebrate World Childrens Day, a day dedicated to raising awareness about children’s rights and welfare. This special date marks the adoption…
Tiefenbacher Group celebrating World Diabetes Day
Diabetes and well-being is the theme for World Diabetes Day 2024-26. On November 14th, we join the global community in recognizing World Diabetes Day, a day dedicated to raising awareness about the…
Tiefenbacher Group Mental Health Day
Prioritizing Mental Health in a Busy World In honor of World Mental Health Day this October, Tiefenbacher Group organized a “Mental Health Awareness Day” for all our employees at AET…
Tiefenbacher Group employee benefits
The Tiefenbacher Group employee benefits programme in Hamburg offers a wide range of options for back care and prevention of back pain. As a 100% family-owned leading healthcare company, we care…
Tiefenbacher Group celebrating Delorbis 10th Birthday
Tiefenbacher Group celebrating a Decade of Excellence: Tiefenbacher Group is delighted to announce a significant milestone in the journey of Delorbis Pharmaceuticals Ltd, our state-of-the-art…
Tiefenbacher Group CPHI Milan 2024
Tiefenbacher Group reflecting on incredible days at CPHI in Milan!We had the pleasure of engaging in many inspiring conversations over the course of the three days, reconnecting with…
Tiefenbacher Laboratories supports victims of Rahat floods
Tiefenbacher Laboratories employees in India actively participated in Goonj’s material collection drives to support the victims of the Rahat floods. Tiefenbacher Group’s Hyderabad facility is a key…
Pioneering Healthcare at Tiefenbacher Group
Curiosity Driven, Excellence Focused, Patient Centered At Tiefenbacher Group, we believe that our expertise must be leveraged for the greater good – to improve patients’ lives worldwide by pioneering…
Tiefenbacher Group Celebrating World Pharmacists Day
On this World Pharmacists Day, we at Tiefenbacher Group join the global community in celebrating the theme “Pharmacists: Meeting global health needs”. This day, organized by the International…
Tiefenbacher Pharmaceuticals New Market Launch: Ezetimibe/Atorvastatin
Tiefenbacher Pharmaceuticals successfully prepares the launch of the generic version of Ezetimibe/Atorvastatin across the European Union We at Tiefenbacher Pharmaceuticals strongly believe that…
Tiefenbacher Group International Night 2024
Tiefenbacher Group celebrates 3rd International Night We are thrilled to look back on our 3rd International Night, an annual tradition that celebrates all international employees who have joined the…
Tiefenbacher Group Earns EcoVadis Silver Medal!
Exciting News: Tiefenbacher Group Earns EcoVadis Silver Medal!We are thrilled to announce that Tiefenbacher Group has been awarded the EcoVadis Silver Medal, highlighting our strong commitment to…
OYSTA receives UX Design Award 2024
We are happy to announce that our beloved OYSTA project has been awarded with the prestigious UX Design Award.Thanks to the outstanding work of our partner Star, a global technology…
Tiefenbacher Pharmaceuticals First to Market Launch: Varenicline in Europe
Tiefenbacher Pharmaceuticals successfully prepares the launch of Varenicline in the European Union We at Tiefenbacher Pharmaceuticals strongly believe that our high-quality medicines should be…
Tiefenbacher Laboratories Blood Donation Camp
Tiefenbacher Laboratories celebrates "International Humanitarian Day" with a blood donation camp Today we are celebrating “International Humanitarian Day” with a blood donation camp on…
Pioneering Healthcare at Tiefenbacher Group
Curiosity Driven, Excellence Focused, Patient Centered At Tiefenbacher Group, we believe that our expertise must be leveraged for the greater good – to improve patients’ lives worldwide by pioneering…
Tiefenbacher Group Employee Self-Care Day
Employee Self-Care Day at Tiefenbacher Group, Hyderabad, India We’re thrilled to announce the successful conclusion of our Employee Self-Care Day! Our team in Hyderabad came together for an…
Tiefenbacher Group partnering with Pharmacists Without Borders
Today we are very pleased to announce that Tiefenbacher Group is expanding the support for Pharmacists Without Borders, a non-profit organization that is close to our hearts and our pharmaceutical…
Tiefenbacher Group Pilates & Yoga
At Tiefenbacher Group, we start the day with Yoga and Pilates At Tiefenbacher Group, we attach great importance to the well-being and health of our employees. That’s why we offer two free Yoga…
Tiefenbacher Group Social Day 2024
Tiefenbacher Group Employees Give Back to the Community On the Tiefenbacher Group Social Day 2024, our employees once again took an active role in supporting the local community by volunteering with…
New laboratory and production site for Oncology medicines
Did you know that Tiefenbacher Group is in the final phase of constructing a new, state-of-the-art laboratory and production site for highly potent drugs against cancer and other…
Tiefenbacher Group celebrating US Independence Day
Today is one of the most important public holidays in the United States of America, celebrating its freedom. At the 4th July 1776, by the adoption of the Declaration of Independence, it declared its…
Tiefenbacher Group “Bike to work days”
This month, some of our valued Tiefenbacher Group colleagues took part in the "Bike to Work Days". A total of 786 journeys to work were made by bike and an incredible 15,000 kilometers were cycled!…
Tiefenbacher Group Luncheon in Hyderabad
It is a tradition at Tiefenbacher Group that our new employees can take part in an open table talk and luncheon with the leadership team, this time in Hyderabad. This involves an open discussion…
Tiefenbacher Group Football Cup 2024
Just in time for the start of the UEFA Euro 2024 kick off in Germany, the Tiefenbacher Group in Hamburg organized its annual football tournament. This year, more than 200 people (employees and their…
Tiefenbacher Group draws attention to blood donation
On today's World Blood Donor Day, Tiefenbacher Group would like to actively support the Red Cross blood donation services and draw attention to blood donation and its importance for society with the…
Tiefenbacher New Market Launch: Buprenorphine in Australia
Tiefenbacher Pharmaceuticals successfully prepared the launch of the analgesic Buprenorphine as Transdermal Patch in Australia. We at Tiefenbacher Pharmaceuticals strongly believe that our…
Tiefenbacher New Market Launch: Bilastine as Oral Dispersible Tablet (ODT)
Tiefenbacher Pharmaceuticals successfully prepared the launch of the antihistamine Bilastine as Oral Dispersible Tablet (ODT) medicine in Germany As the allergy season is in full swing, we at…
Tiefenbacher Group celebrates The International Day of Families
Today we celebrate The International Day of Families! We would like to use the International Day of Families to talk about our Tiefenbacher Group family. Since 1963 Tiefenbacher Group…
TIEFENBACHER API + INGREDIENTS offers custom synthesis of intermediates & APIs
Synthesis of Active Pharmaceutical Ingredients (API) : From route scouting to lab scale development to commercial supply Did you know that Tiefenbacher API + Ingredients not only…
Tiefenbacher Group renovation of headquarters in Hamburg
Tiefenbacher Group is keeping you updated on the ongoing renovation of our headquarters at the Port of Hamburg in Germany. This month we reopened our 3rd floor and we are happy to present you some of…
Tiefenbacher Group invites young people to Girls’ & Boys’ Day
Tiefenbacher Group invited some of our employees' children in Hamburg to spend a day with us at our headquarters to mark Germany's Future Day for young people. The Girls’ & Boys’ Day…
Tiefenbacher Group celebrates Earth Day 2024
We are pleased to inform you that TIEFENBACHER GROUP is successfully on its way to becoming climate neutral by the end of 2025*. Every year, Earth Day provides the keynote for a wide range of…
Tiefenbacher first-to-market launch: Rivaroxaban
Tiefenbacher Pharmaceuticals successfully prepares the launch of the anticoagulant Rivaroxaban.We at Tiefenbacher Pharmaceuticals strongly believe that our high-quality medicines should be affordable…
Tiefenbacher Group welcomes new COO Sandip Tarate
We are pleased to welcome our new COO for AET Laboratories, Sandip Tarate, to Tiefenbacher Group.Sandip has joined our site in Hyderabad, India, with 23+ years of extensive experience in the…
Tiefenbacher Group raises awareness of autism
Tiefenbacher Group raises awareness of autism on today's World Autism Awareness Day.The aim of World Autism Awareness Day is to draw attention to the needs and lifelong struggles of…
Tiefenbacher Group awarded EcoVadis silver medal!
We are excited to share that Tiefenbacher API + Ingredients has been awarded the EcoVadis Silver Medal!EcoVadis is the world’s largest provider of business sustainability ratings. The EcoVadis…
Tiefenbacher Group celebrates International Women’s Day
Today Tiefenbacher Group celebrates International Women's Day, that's why we would like to introduce you to two valuable female employees from our company.Get to know the women who are working at…
Tiefenbacher Group on awareness for rare disease day
Tiefenbacher Group draws attention to Rare Disease Day.Today we are focusing on awareness and generating change for the 300 million people worldwide living with rare diseases. Treatment for many rare…
Tiefenbacher Group supports Pharmacists in Ukraine
Tiefenbacher Group supporting people in Ukraine by donating to Pharmacists without borders.The 24 February 2024, marks the second anniversary of the brutal Russian war against a sovereign Ukraine.…
Tiefenbacher Group renovation of headquarters
Tiefenbacher Group keeping you updated on the ongoing renovation of our headquarters at the Port of Hamburg in Germany.Tiefenbacher Group is happy to present some of the results of the remodelling…
Tiefenbacher Group wishes a Happy Chinese New Year!
The Chinese New Year is almost here.On the 10th of February, people around the world celebrate the Chinese New Year. They honour this day with carnival events, family gatherings, parades, traditional…
Tiefenbacher Group together against blood cancer
Tiefenbacher Group and DKMS together against blood cancer!We are pleased to inform you that we have initiated a DKMS registration event during the last week in our headquartes in Hamburg to look for…
Tiefenbacher speaks out against racism and supports diversity
Tiefenbacher Group speaks out against racism and supports diversityTiefenbacher recognises its responsibility to be a force for good with its pharmaceuticals. Additionally our wider actions aim to…
Tiefenbacher Group AET Laboratories 20th anniversary celebration
AET Laboratories 20th anniversary celebration was a tremendous success!Last year, we not only celebrated Tiefenbacher Group´s 60th anniversary in Hamburg, but also the 20th…
Tiefenbacher Group wishes you a happy new year!
As 2023 draws to a close, the Tiefenbacher Group would like to share some of the year's highlights with you. This year we not only had our 60th anniversary to celebrate, but also many…
Tiefenbacher New Market Launch: Rivaroxaban in Canada
Tiefenbacher Pharmaceuticals successfully launches the anticoagulant Rivaroxaban on day one in CanadaWe at Tiefenbacher Pharmaceuticals strongly believe that our high-quality medicines should be…
Tiefenbacher Group 60 years of pioneering healthcare!
60 years of pioneering healthcare at Tiefenbacher GroupTiefenbacher Group says “Thank you” to our colleagues from our three main locations in Hamburg (Germany), Hyderabad…
Tiefenbacher Group 60 years anniversary celebration!
60 years anniversary celebrationsWe are very happy to announce that Tiefenbacher Group celebrates its 60th anniversary this year! 60 years ago, our founder and pioneer Alfred E.…
Tiefenbacher Group sustainable impact in Hyderabad/India
Tiefenbacher Group relocation of trees in Hyderabad – contribution to our India community to make life better for people and planetAt Tiefenbacher Group, we know that our responsibility as a global…
Tiefenbacher New Market Launch: generic launch Teriflunomide
New market launch: Tiefenbacher Pharmaceuticals successfully launches the generic version of Teriflunomide in more than 20 European countriesTiefenbacher Pharmaceuticals has successfully prepared a…
State-of-the-art R&D facilities for powerful drug development
State-of-the-art R&D facilities for powerful drug development and manufacturing. New technology for generic, valued added, and innovative pharmaceuticalsWe, at Tiefenbacher Group, go beyond…
Tiefenbacher Group Social Day 2023: Community Engagement
Tiefenbacher Group Social Day 2023 – contribution through our social and community engagement in HamburgTiefenbacher Group employees get involved in the local community by volunteering with local…
Tiefenbacher Community engagement: School in Hyderabad /India
Tiefenbacher Social Responsibility & Community engagement: New School in Hyderrabad /India – taking action to ensure a positive impact for children and a better future Tiefenbacher…
TIEFENBACHER API + INGREDIENTS offers Raw Material for Animal Health
TIEFENBACHER API + INGREDIENTS offers Raw Material for Animal Health: Companion and Farm AnimalsDid you know that Tiefenbacher API + Ingredients offers in addition to its extensive…
OYSTA: Launch of new OYSTA website
Launch of new OYSTA websiteWe are happy that we have launched a new web page for OYSTA – an innovative healthcare brand which we have developed together with our partner OnDosis. With…
SFDA approves Tiefenbacher facilities
Tiefenbacher: Own manufacturing and laboratory facilities successfully registered by the Saudi Food and Drug Authority (SFDA) for GCC regionThe SFDA approves Tiefenbacher facilities! We are happy to…
Tiefenbacher Group is committed to becoming climate neutral
Tiefenbacher Group is committed to becoming climate neutral by the end of 2025 - sustainability contribution to make life better for people and planetWe are pleased to share that TIEFENBACHER GROUP…
Tiefenbacher Group: Renovating Headquarters in Hamburg
Tiefenbacher Group: Renovating Headquarters in Hamburg /Germany – an agile, open-plan work spaceTiefenbacher Group is renovating the Headquarters in Hamburg for flexible working while…
Tiefenbacher Group at DCAT week 2023
Tiefenbacher Group at DCAT 2023 – Thanks for meeting us in New York City!It has been four very successful and inspiring days for TIEFENBACHER GROUP in New York City. We were delighted…
Tiefenbacher Generic Launch: antihistamine Bilastine
Generic Launch: Tiefenbacher Pharmaceuticals successfully launches the antihistamine Bilastine for a market entry as over-the-counter (OTC) medicine in germanyGeneric drugs: As the allergy season is…
Tiefenbacher registered by United Arab Emirates Ministry of Health
Tiefenbacher Group manufacturing sites have been successfully registered by the United Arab Emirates Ministry of HealthThe Tiefenbacher Group is very excited to announce that our two manufacturing…
Tiefenbacher marks World Cancer Day 2023
TIEFENBACHER marks 'World Cancer Day 2023' to increase awareness prevention throughout media togetherTIEFENBACHER joined to harness the power of social media to raise awareness on cancer early…
Tiefenbacher Group wishes a happy Chinese New Year 2023!
We at Tiefenbacher Group appreciate the diversity of our colleagues very much and are happy to celebrate their local traditions together. This year, on the 22nd of January, people…
Tiefenbacher Group wishes a healthy New Year 2023
From all over the world, we wish you a happy and healthy New Year 2023!Tiefenbacher Group wishes a everyone a healthy New Year. We hope the year 2023 will be as successful and full of…
Tiefenbacher Pharmaceuticals New Market Launch: Apremilast (Psoriasis)
New Market Launch: TIEFENBACHER PHARMACEUTICALS successfully launches generic version of the psoriasis medication Apremilast in CanadaWe at Tiefenbacher Pharmaceuticals strive to make our…
Tiefenbacher Pharmaceuticals New Market Launch: Abiraterone for prostate cancer
New Market Launch: TIEFENBACHER PHARMACEUTICALS successfully launces generic version of the prostate cancer medicines Abiraterone and the value-added product Abiraterone/PrednisoloneWe at…
Thanks for visiting us at CPhI 2022 in Frankfurt!
Tiefenbacher Group: Three Successful Days at CPhI 2023 - Thank you for visiting us in Barcelona!
TIEFENBACHER GROUP opens new manufacturing site in Cyprus
TIEFENBACHER GROUP opens new manufacturing site in Cyprus for drug production of high-quality pharmaceuticals – we continuously expand in novel technologies and capabilities to improve quality and…
Tiefenbacher Pharmaceuticals New Market Launch: Apixaban anticoagulant
New Market Launch: TIEFENBACHER PHARMACEUTICALS successfully launches generic version of the anticoagulant medicine Apixaban in CanadaWe at Tiefenbacher Pharmaceuticals are driven by enabling people…
Meet TIEFENBACHER GROUP at CPhI 2022 in Frankfurt /Germany
Meet TIEFENBACHER GROUP at CPhI in Frankfurt from 1-3 Nov and discover our latest ideas to make pharmaceuticals more affordable, more available, and better than before!We are very excited to meet our…
Tiefenbacher Pharmaceuticals New Market Launch: Vildagliptin/Metformin
NEW Market Launch: TIEFENBACHER PHARMACEUTICALS successfully launches generic version of the diabetes medicine Vildagliptin and Vildagliptin /Metformin in AfricaWe at Tiefenbacher Pharmaceuticals…
Tiefenbacher: Employee benefits and climate reduction goals
Environmentally friendly and health-promoting: TIEFENBACHER GROUP offers bike leasing to employeesEmployees benefits while reducing our impact on the environment with climate reduction goals – we…
Tiefenbacher Pharmaceuticals New Market Launch: Rivaroxaban
Global market launch: TIEFENBACHER PHARMACEUTICALS expands the launch of the anticoagulant medicine Rivaroxaban to Central America and further international marketsWe at Tiefenbacher Pharmaceuticals…
Tiefenbacher Pharmaceuticals New Market Launch: Teriflunomide
NEW MARKET LAUNCH: TIEFENBACHER PHARMACEUTICALS SUCCESSFULLY LAUNCHES FIRST GENERIC VERSION OF THE MULTIPLE SCLEROSIS MEDICINE TERIFLUNOMIDE IN CANADAWe at Tiefenbacher Pharmaceuticals strive to make…
Sustainability: TIEFENBACHER GROUP becomes member of the Pharmaceutical Supply Chain Initiative (PSCI)
TIEFENBACHER GROUP becomes member of the Pharmaceutical Supply Chain Initiative (PSCI) – contribution to make life better for people and planetWe at TIEFENBACHER GROUP are committed to promote…
TIEFENBACHER GROUP OPENS NEW SITE FOR HIGHLY POTENT DRUGS IN INDIA
TIEFENBACHER GROUP opens new site for highly potent drugs in India – we continuously expand in novel technologies and capabilities to improve quality and boost productivity of better…
WORLD HEALTH DAY @ TIEFENBACHER GROUP
World Health Day is on the 7th of April each year – this day marks the anniversary of the World Health Organization which was founded in 1948.Today we celebrate World Health Day. This Day marks the…
TIEFENBACHER AT DCAT 2022 IN NEW YORK CITY! – Thanks for Meeting us
TIEFENBACHER GROUP AT DCAT 2022 – THANKS FOR MEETING US IN NEW YORK CITY! One of the world´s most important pharma events – DCAT-Week in New York City – has just come to an end. It was…
Tiefenbacher Pharmaceuticals New Market Launch: Lacosamide
NEW MARKET LAUNCH: TIEFENBACHER PHARMACEUTICALS SUCCESSFULLY LAUNCHES FIRST GENERIC VERSION OF THE EPILEPSY MEDICINE LACOSAMIDE IN AUSTRALIAWe at Tiefenbacher Pharmaceuticals strongly believe that…
TIEFENBACHER GROUP stands with UKRAINE
Peace and freedom for Ukraine: We, a healthcare company in Europe, stand in solidarity with the people in UkraineTo us at Tiefenbacher Group, it is unbearable to witness what is happening in Ukraine.…
MEET TIEFENBACHER GROUP DURING DCAT WEEK IN NEW YORK CITY 2022
Meet TIEFENBACHER GROUP during DCAT week in New York City 2022 from 21-24th march!Reach out to TIEFENBACHER GROUP at DCAT in New York City from 21-24th March and discover our latest ideas to make…
TIEFENBACHER GROUP WISHES A HAPPY AND HEALTHY NEW YEAR 2022 FROM ALL OVER THE WORLD!
We at TIEFENBACHER GROUP wish you a happy and healthy new year 2022 from all over the world! Please watch the short video for our new year greetings from our colleagues from our three…
TIEFENBACHER GROUP enlarges its manufacturing facilities in India and Cyprus
Driving efficiency is our key – TIEFENBACHER GROUP enlarges its manufacturing facilities in India and Cyprus for powerful drug productionDid you know that TIEFENBACHER GROUP heavily invests in its…
TIEFENBACHER GROUP at CPhI 2021 in Milano – thank you for visiting us!
Tiefenbacher Group: Three Successful Days at CPHI 2021 in Milano - Thank you for visiting usWith over 1,300 exhibitors and more than 20,000 attendees the world`s leading pharma eventt…
TIEFENBACHER GROUP: New school building in India
At TIEFENBACHER GROUP giving back to society is important to us: New school building in India As a value-driven healthcare company, dedicated to improve the life of patients worldwide,…
TIEFENBACHER GROUP at CPhI in Milan 2021
Reach out to the TIEFENBACHER GROUP at CPHI in Milan 2021 and discover our latest innovations to make pharmaceuticals more affordable, more available, and better than before.“Nothing can replace…
Tiefenbacher Pharmaceuticals: Launch of first generic version of the antihistamine Bilastine
New market launch: TIEFENBACHER PHARMACEUTICALS successfully launches first generic version of the antihistamine BilastineWe at Tiefenbacher Pharmaceuticals strongly believe that our high-quality…
New agreement expands collaboration between OnDosis and TIEFENBACHER GROUP
Innovative Healthcare Pharmaceuticals with e-health technology in the ADHD field, rare diseases, and transplantation medicineSwedish Life science company OnDosis and German B2B pharmaceutical company…
TIEFENBACHER GROUP supports Post COVID-19 with Posaconazole against Black Fungus (Mucormycosis)
TIEFENBACHER GROUP supports Post COVID-19 with Posaconazole tablets against Black Fungus (Mucormycosis) in IndiaBlack Fungus (Mucormycosis) is dramatically spreading in India connected to the…
TIEFENBACHER GROUP announces global launch of TIEFENBACHER MEDICAL DEVICES
Innovation healthcare by combining established drug-based medicines with medical devices and digital healthAfter more than five years in operation, TIEFENBACHER GROUP transfer its medical device…
TIEFENBACHER API + INGREDIENTS: FIRST API BASED ON GREEN CHEMISTRY
TIEFENBACHER API + INGREDIENTS starts to offer the first API based on green chemistryWe at TIEFENBACHER API + INGREDIENTS are committed to drive greem chemistry in the pharmaceutical raw material…
TIEFENBACHER PHARMACEUTICALS: Launch of generic version of Teriflunomide, Multiple Sclerosis (MS)
TIEFENBACHER PHARMACEUTICALS announces global generic launch of Teriflunomide – making multiple sclerosis therapy more affordable and better available worldwideTiefenbacher Pharmaceuticals has…
AET Pharma US Inc., Part of Tiefenbacher, approval of Abbreviated New Drug Application (ANDA) for Posaconazole
AET Pharma US Inc. announces successful approval of Abbreviated New Drug Application (ANDA) for PosaconazoleOn 1st February 2021, AET Pharma US Inc, part of TIEFENBACHER GROUP, received FDA approval…
TIEFENBACHER PHARMACEUTICALS: Launch of Rivaroxaban
TIEFENBACHER PHARMACEUTICALS announces global launch of Rivaroxaban – an anticoagulant medication (blood thinner)Tiefenbacher Pharmaceuticals, part of Tiefenbacher Group, is pleased to announce the…
International Brand Relaunch of Tiefenbacher Group
Tiefenbacher Group: Improving people’s life by making pharmaceuticals more affordable, more available, and better than before“We are very excited to launch the new Tiefenbacher Group website.…
Tiefenbacher Group and OnDosis enter a partnership for medicines and digital health
Tiefenbacher Group and OnDosis today announced the signing of an extensive co-development agreement for multiple products in the upcoming years. This collaboration strengthens both companies’…
